Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Becker

Showing results (121-130 of 141) with videos related to

Pageof 15
Sort By:
American Heart Journal|November 13, 1998
Use of bedside activated partial thromboplastin time monitor to adjust heparin dosing after thrombolysis for acute myocardial infarction: results of GUSTO-I. Global Utilization of Streptokinase and TPA for Occluded Coronary ArteriesK M Zabel, C B Granger, R C Becker, et al.
Cardiology|January 1, 1991
Heparin pharmacokinetics and in vitro anticoagulant activity in patients receiving nonionic radiographic contrast mediaR C Becker, C Clyne, B H Weiner, et al.
American Heart Journal|March 1, 1996
Relation between systemic anticoagulation as determined by activated partial thromboplastin time and heparin measurements and in-hospital clinical events in unstable angina and non-Q wave myocardiaL infarction. Thrombolysis in Myocardial Ischemia III B InvestigatorsR C Becker, C P Cannon, R P Tracy, et al.
American Heart Journal|June 1, 1990
Intravenous nitroglycerin-induced heparin resistance: a qualitative antithrombin III abnormalityR C Becker, J M Corrao, E G Bovill, et al.
American Heart Journal|May 1, 1990
Impact of atrial fibrillation on the in-hospital and long-term survival of patients with acute myocardial infarction: a community-wide perspectiveR J Goldberg, D Seeley, R C Becker, et al.
Journal of the American College of Cardiology|February 14, 1998
Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery diseaseM I Furman, S E Benoit, M R Barnard, et al.
American Heart Journal|May 20, 1998
Early assessment and in-hospital management of patients with acute myocardial infarction at increased risk for adverse outcomes: a nationwide perspective of current clinical practice. The National Registry of Myocardial Infarction (NRMI-2) ParticipantsR C Becker, M Burns, J M Gore, et al.
The American Journal of Cardiology|September 1, 1996
Usefulness of fibrinogenolytic and procoagulant markers during thrombolytic therapy in predicting clinical outcomes in acute myocardial infarction. TIMI-5 Investigators. Thrombolysis in Myocardial InfarctionJ S Scharfstein, D R Abendschein, P R Eisenberg, et al.
Journal of Thrombosis and Haemostasis : JTH|August 21, 2009
Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysisS G Chu, R C Becker, P B Berger, et al.
Journal of the American College of Cardiology|July 1, 1997
Outcome and profile of women and men presenting with acute coronary syndromes: a report from TIMI IIIB. TIMI Investigators. Thrombolysis in Myocardial InfarctionJ S Hochman, C H McCabe, P H Stone, et al.
Pageof 15

Showing results (121-130 of 141) with videos related to

Sort By:
Pageof 15
American Heart Journal|November 13, 1998
Use of bedside activated partial thromboplastin time monitor to adjust heparin dosing after thrombolysis for acute myocardial infarction: results of GUSTO-I. Global Utilization of Streptokinase and TPA for Occluded Coronary ArteriesK M Zabel, C B Granger, R C Becker, et al.
Cardiology|January 1, 1991
Heparin pharmacokinetics and in vitro anticoagulant activity in patients receiving nonionic radiographic contrast mediaR C Becker, C Clyne, B H Weiner, et al.
American Heart Journal|March 1, 1996
Relation between systemic anticoagulation as determined by activated partial thromboplastin time and heparin measurements and in-hospital clinical events in unstable angina and non-Q wave myocardiaL infarction. Thrombolysis in Myocardial Ischemia III B InvestigatorsR C Becker, C P Cannon, R P Tracy, et al.
American Heart Journal|June 1, 1990
Intravenous nitroglycerin-induced heparin resistance: a qualitative antithrombin III abnormalityR C Becker, J M Corrao, E G Bovill, et al.
American Heart Journal|May 1, 1990
Impact of atrial fibrillation on the in-hospital and long-term survival of patients with acute myocardial infarction: a community-wide perspectiveR J Goldberg, D Seeley, R C Becker, et al.
Journal of the American College of Cardiology|February 14, 1998
Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery diseaseM I Furman, S E Benoit, M R Barnard, et al.
American Heart Journal|May 20, 1998
Early assessment and in-hospital management of patients with acute myocardial infarction at increased risk for adverse outcomes: a nationwide perspective of current clinical practice. The National Registry of Myocardial Infarction (NRMI-2) ParticipantsR C Becker, M Burns, J M Gore, et al.
The American Journal of Cardiology|September 1, 1996
Usefulness of fibrinogenolytic and procoagulant markers during thrombolytic therapy in predicting clinical outcomes in acute myocardial infarction. TIMI-5 Investigators. Thrombolysis in Myocardial InfarctionJ S Scharfstein, D R Abendschein, P R Eisenberg, et al.
Journal of Thrombosis and Haemostasis : JTH|August 21, 2009
Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysisS G Chu, R C Becker, P B Berger, et al.
Journal of the American College of Cardiology|July 1, 1997
Outcome and profile of women and men presenting with acute coronary syndromes: a report from TIMI IIIB. TIMI Investigators. Thrombolysis in Myocardial InfarctionJ S Hochman, C H McCabe, P H Stone, et al.
Pageof 15